{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T01:36:54Z","timestamp":1792201014414,"version":"4.4.0"},"reference-count":33,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1645,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1111\/j.1399-5618.2011.00898.x","type":"journal-article","created":{"date-parts":[[2011,3,28]],"date-time":"2011-03-28T20:20:39Z","timestamp":1301343639000},"page":"133-144","source":"Crossref","is-referenced-by-count":103,"title":["Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study"],"prefix":"10.1111","volume":"13","author":[{"given":"Ronald","family":"Marcus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arif","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Rollin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Timko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Carson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,3,28]]},"reference":[{"key":"10.1111\/j.1399-5618.2011.00898.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"870","DOI":"10.4088\/JCP.v66n0710","article-title":"The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder","volume":"66","author":"Suppes","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1111\/j.1399-5618.2011.00898.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1177\/0269881109102919","article-title":"Evidence-based guidelines for treating bipolar disorder: revised second edition-recommendations from the British Association for Psychopharmacology","volume":"23","author":"Goodwin","year":"2009","journal-title":"J Psychopharmacol"},{"key":"10.1111\/j.1399-5618.2011.00898.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/15622970902823202","article-title":"The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania","volume":"10","author":"Grunze","year":"2009","journal-title":"World J Biol Psychiatry"},{"key":"10.1111\/j.1399-5618.2011.00898.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1399-5618.2009.00672.x","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009","volume":"11","author":"Yatham","year":"2009","journal-title":"Bipolar Disord"},{"key":"10.1111\/j.1399-5618.2011.00898.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.euroneuro.2009.04.003","article-title":"Advantages and disadvantages of combination treatment with antipsychotics. ECNP Consensus Meeting, March 2008, Nice","volume":"19","author":"Goodwin","year":"2009","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1111\/j.1399-5618.2011.00898.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/archpsyc.1973.01750330035006","article-title":"Prophylactic efficacy of lithium carbonate in manic-depressive illness. Report of the Veterans Administration and National Institute of Mental Health collaborative study group","volume":"28","author":"Prien","year":"1973","journal-title":"Arch Gen Psychiatry"},{"key":"10.1111\/j.1399-5618.2011.00898.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/archpsyc.57.5.481","article-title":"A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group","volume":"57","author":"Bowden","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"10.1111\/j.1399-5618.2011.00898.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/archpsyc.60.4.392","article-title":"A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder","volume":"60","author":"Bowden","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"10.1111\/j.1399-5618.2011.00898.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.4088\/JCP.v64n0906","article-title":"A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder","volume":"64","author":"Calabrese","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1111\/j.1399-5618.2011.00898.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1176\/appi.ajp.163.2.247","article-title":"Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine","volume":"163","author":"Tohen","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1111\/j.1399-5618.2011.00898.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.4088\/JCP.v68n1003","article-title":"Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo","volume":"68","author":"Keck","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"10.1111\/j.1399-5618.2011.00898.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1176\/appi.ajp.162.7.1281","article-title":"Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial","volume":"162","author":"Tohen","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1111\/j.1399-5618.2011.00898.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"130","DOI":"10.4088\/JCP.09m05482yel","article-title":"Ziprasidone plus a mood stabilizer in subjects with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind trial","volume":"71","author":"Bowden","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"10.1111\/j.1399-5618.2011.00898.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1176\/appi.ajp.2008.08020189","article-title":"Maintenance treatment for patients with bipolar I disorder: results from a north american study of quetiapine in combination with lithium or divalproex (trial 127)","volume":"166","author":"Suppes","year":"2009","journal-title":"Am J Psychiatry"},{"key":"10.1111\/j.1399-5618.2011.00898.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jad.2008.06.001","article-title":"Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126)","volume":"109","author":"Vieta","year":"2008","journal-title":"J Affect Disord"},{"key":"10.1111\/j.1399-5618.2011.00898.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1192\/bjp.184.4.337","article-title":"Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone","volume":"184","author":"Tohen","year":"2004","journal-title":"Br J Psychiatry"},{"key":"10.1111\/j.1399-5618.2011.00898.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1124\/jpet.102.033175","article-title":"Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors","volume":"302","author":"Burris","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/j.1399-5618.2011.00898.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0014-2999(02)01532-7","article-title":"The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor","volume":"441","author":"Jordan","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/j.1399-5618.2011.00898.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1038\/sj.npp.1300203","article-title":"Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology","volume":"28","author":"Shapiro","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1111\/j.1399-5618.2011.00898.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1176\/appi.ajp.2008.07101560","article-title":"Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially non-responsive to valproate\/lithium monotherapy: a placebo-controlled study","volume":"165","author":"Vieta","year":"2008","journal-title":"Am J Psychiatry"},{"key":"10.1111\/j.1399-5618.2011.00898.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1185\/03007991003779380","article-title":"Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium\/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study","volume":"26","author":"Vieta","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"10.1111\/j.1399-5618.2011.00898.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br J Psychiatry"},{"key":"10.1111\/j.1399-5618.2011.00898.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br J Psychiatry"},{"key":"10.1111\/j.1399-5618.2011.00898.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0165-1781(97)00123-6","article-title":"Modification of the Clinical Global Impressions (CGI) scale for use in bipolar illness (BP): the CGI-BP","volume":"73","author":"Spearing","year":"1997","journal-title":"Psychiatry Res"},{"key":"10.1111\/j.1399-5618.2011.00898.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"10.1111\/j.1399-5618.2011.00898.x-BIB26|cit26","first-page":"534","volume-title":"ECDEU Assessment Manual for Psychopharmacology. US Department of Health, Education, and Welfare publication (ADM) 76-338","author":"Guy","year":"1976"},{"key":"10.1111\/j.1399-5618.2011.00898.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1192\/bjp.154.5.672","article-title":"A rating scale for drug-induced akathisia","volume":"154","author":"Barnes","year":"1989","journal-title":"Br J Psychiatry"},{"key":"10.1111\/j.1399-5618.2011.00898.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1185\/03007995.2010.489830","article-title":"Improving the design of maintenance studies for bipolar disorder","volume":"26","author":"Gitlin","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"10.1111\/j.1399-5618.2011.00898.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1399-5618.2007.00520.x","article-title":"Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder","volume":"10","author":"van Winkel","year":"2008","journal-title":"Bipolar Disord"},{"key":"10.1111\/j.1399-5618.2011.00898.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2165\/00023210-200822080-00004","article-title":"Bipolar disorder and the metabolic syndrome: causal factors, psychiatric outcomes and economic burden","volume":"22","author":"Fagiolini","year":"2008","journal-title":"CNS Drugs"},{"key":"10.1111\/j.1399-5618.2011.00898.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.eurpsy.2007.07.005","article-title":"Metabolic syndrome in outpatients receiving antipsychotic therapy in routine clinical practice: a cross-sectional assessment of a primary health care database","volume":"23","author":"Sicras-Mainar","year":"2008","journal-title":"Eur Psychiatry"},{"key":"10.1111\/j.1399-5618.2011.00898.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1177\/070674370104600308","article-title":"Antipsychotic metabolic effects: weight gain, diabetes mellitus, and lipid abnormalities","volume":"46","author":"McIntyre","year":"2001","journal-title":"Can J Psychiatry"},{"key":"10.1111\/j.1399-5618.2011.00898.x-BIB33|cit33","first-page":"76","article-title":"Mental disorders and metabolic syndrome: a fatamorgana or warning reality?","volume":"19","author":"Jakovljevi\u0107","year":"2007","journal-title":"Psychiatr Danub"}],"container-title":["Bipolar Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-5618.2011.00898.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1399-5618.2011.00898.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T18:58:36Z","timestamp":1625597916000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-5618.2011.00898.x"}},"subtitle":["Adjunctive aripiprazole in bipolar disorder"],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,3]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1399-5618.2011.00898.x","relation":{},"ISSN":["1398-5647"],"issn-type":[{"value":"1398-5647","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}